Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.03B |
| 2 |
Qualcomm
QCOM
|
+$924M |
| 3 |
Walmart Inc
WMT
|
+$794M |
| 4 |
Marvell Technology
MRVL
|
+$738M |
| 5 |
Amazon
AMZN
|
+$608M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.19B |
| 2 |
GE Aerospace
GE
|
+$1.14B |
| 3 |
Advanced Micro Devices
AMD
|
+$931M |
| 4 |
Intel
INTC
|
+$877M |
| 5 |
NVIDIA
NVDA
|
+$873M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.12% |
| 2 | Consumer Discretionary | 10.16% |
| 3 | Financials | 9.68% |
| 4 | Healthcare | 9.27% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1776
CONMED
CNMD
$1.48B
| $300K | ﹤0.01% |
9,170
+2,969
| +48% | +$107K |
2026 Q1
1 quarter
|
|
1777
BW LPG
BWLP
$3.75B
| $298K | ﹤0.01% |
17,080
+5,909
| +53% | +$116K |
2025 Q4
2 quarters
|
|
1778
PVH
PVH
$3.89B
| $297K | ﹤0.01% |
4,001
-6,546
| -62% | -$560K |
2025 Q4
2 quarters
|
|
1779
Axos Financial
AX
$5.25B
| $297K | ﹤0.01% |
3,047
| – | – |
2026 Q1
1 quarter
|
|
1780
Remitly
RELY
$5.36B
| $297K | ﹤0.01% |
13,240
-5,445
| -29% | -$112K |
2026 Q1
1 quarter
|
|
1781
National Healthcare
NHC
$3.81B
| $297K | ﹤0.01% |
+1,403
| New | +$258K |
2026 Q2
0 quarters
|
|
1782
Flagstar Bank National Association
FLG
$4.75B
| $295K | ﹤0.01% |
19,716
| – | – |
2025 Q4
2 quarters
|
|
1783
Biohaven
BHVN
$2.22B
| $294K | ﹤0.01% |
19,749
| – | – |
2025 Q4
2 quarters
|
|
1784
The Greenbrier Companies
GBX
$1.2B
| $293K | ﹤0.01% |
5,974
+820
| +16% | +$40.3K |
2023 Q1
13 quarters
|
|
1785
United Parks & Resorts
PRKS
$1.41B
| $293K | ﹤0.01% |
6,128
| – | – |
2026 Q1
1 quarter
|
|
1786
Certara
CERT
$1.54B
| $292K | ﹤0.01% |
44,586
+19,250
| +76% | +$108K |
2023 Q2
12 quarters
|
|
1787
Establishment Labs
ESTA
$1.89B
| $291K | ﹤0.01% |
+3,396
| New | +$244K |
2026 Q2
0 quarters
|
|
1788
Innospec
IOSP
$2.43B
| $290K | ﹤0.01% |
3,565
-5,310
| -60% | -$420K |
2021 Q2
20 quarters
|
|
1789
Novo Nordisk
NVO
$174B
| $288K | ﹤0.01% |
+6,000
| New | +$258K |
2026 Q2
0 quarters
|
|
1790
Regencell Bioscience
RGC
$4.86B
| $287K | ﹤0.01% |
47,159
+38,564
| +449% | +$926K |
2026 Q1
1 quarter
|
|
1791
Dianthus Therapeutics
DNTH
$4.39B
| $287K | ﹤0.01% |
+2,942
| New | +$257K |
2026 Q2
0 quarters
|
|
1792
First Commonwealth Financial
FCF
$2.13B
| $285K | ﹤0.01% |
14,019
-31,818
| -69% | -$601K |
2023 Q2
12 quarters
|
|
1793
Willdan Group
WLDN
$1.1B
| $285K | ﹤0.01% |
3,603
-758
| -17% | -$64.5K |
2025 Q4
2 quarters
|
|
1794
NuScale Power
SMR
$2.21B
| $285K | ﹤0.01% |
28,368
+9,785
| +53% | +$110K |
2025 Q4
2 quarters
|
|
1795
DELISTED
American Express Global Business Travel
GBTG
| $284K | ﹤0.01% |
30,218
| – | – |
2025 Q4
2 quarters
|
|
1796
Haemonetics
HAE
$5.28B
| $284K | ﹤0.01% |
3,780
-2,063
| -35% | -$133K |
2025 Q4
2 quarters
|
|
1797
Alaska Air
ALK
$3.95B
| $283K | ﹤0.01% |
5,429
-54,527
| -91% | -$2.33M |
2026 Q1
1 quarter
|
|
1798
PennyMac Financial
PFSI
$3.29B
| $283K | ﹤0.01% |
+3,250
| New | +$283K |
2026 Q2
0 quarters
|
|
1799
Century Communities
CCS
$1.66B
| $283K | ﹤0.01% |
3,948
-1,131
| -22% | -$65.4K |
2022 Q4
14 quarters
|
|
1800
Ivanhoe Electric
IE
$1.26B
| $282K | ﹤0.01% |
29,348
+15,308
| +109% | +$193K |
2025 Q4
2 quarters
|
|
Similar funds
Amundi's Q2 2026 Portfolio in Review
As of Q2 2026, Amundi held 2,193 positions worth $416B, up 13% from $368B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Amundi's Q2 2026 filing shows 151 new, 827 increased, 930 reduced and 130 closed positions. Its largest new stake was FedEx Freight: 684,463 shares worth $103M. The largest sale was Micron Technology, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Financials.
- Amundi's largest Q2 2026 buy was FedEx Freight: 684,463 shares worth $103M.
- Amundi added most to Microsoft in Q2 2026, an estimated $2.03B increase.
- Amundi's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.19B.
- Amundi fully exited Hologic in Q2 2026, selling an estimated $111M.
- Amundi's ten largest holdings make up 33% of its $416B portfolio in Q2 2026.
- Amundi opened 151 new positions and closed 130 in Q2 2026.
- Amundi's portfolio value rose 13% quarter-over-quarter to $416B.
Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.